FDA applicant
Immunalysis Corporation
FDA records 50 decisions for Immunalysis Corporation (Pomona, CA) from 1978 to 2025: 50 510(k) clearances. Most are in product codes DJG (Enzyme Immunoassay, Opiates) and LAT (Radioimmunoassay, Cannabinoid (S)). Since 2016 its 510(k)s took a median of 380 days from receipt to decision, against 101 for FDA’s reviews in the same codes and years. Its devices cite 29 predicates, 5 of them its own earlier devices. 1 recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Immunalysis Corporation’s devices, and how often a recall has named them.
FDA decisions per year
1in 2025
2026 so far, outlined.
Recalls per year
1in 2017
Class I Class II/III not classified
Planning a device like Immunalysis Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report